Option Care Health (OPCH) Stock: Buy, Sell, or Hold?
OPCH - Option Care Health, Inc. Common Stock
$23.48
-0.15 (-0.63%)
▼
5d:
-4.01%
30d:
-1.51%
90d:
+12.99%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Oct 29, 2026
Get Alerted When OPCH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: OPCH shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: OPCH shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$40.23
Based on 7.3% avg growth
INTRINSIC VALUE TODAY
$24.98
6.0% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 13.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: OPCH is currently trading at $23.48, which is considered oversold relative to its 30-day fair value range of $23.49 to $24.07. From a valuation perspective, the stock is trading at a discount (Forward PE: 11.3) compared to its historical average (13.6). Remarkably, the market is currently pricing in an annual earnings decline of 6.0% over the next few years. This pessimistic expectation contrasts with the company's recent 12.9% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, OPCH is showing sideways momentum. The price is currently testing key support at $23.25. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 42/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $28.58 (+21.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, OPCH is showing sideways momentum. The price is currently testing key support at $23.25. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 42/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $28.58 (+21.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$23.49 -
$24.07
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (42/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 21.7% below Wall St target ($28.58)
- WARNING: Composite score 49/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$23.49 -
$24.07
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$23.25
Resistance Level
$24.52
Current Trend
Sideways
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
11.28
Wall Street Target
$28.58
(+21.7%)
Revenue Growth (YoY)
1.9%
Earnings Growth (YoY)
12.9%
Profit Margin
3.7%
Valuation Discount vs History
-6.0% cheaper
PE vs Historical
11.3 vs 13.6
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-6.0%
(market-implied from PE analysis)
1-Year Target
$22.07
(-6%)
2-Year Target
$20.75
(-12%)
3-Year Target
$19.50
(-17%)
3-Yr Target (if PE normalizes)
(PE: 11→14)
$23.52
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.2, Growth: 10.6%)
$56.83
(+142%)
Base:
(SPY PE: 11.3, Growth: 10.6%)
$31.77
(+35%)
Bear:
(PE: 9.6, Growth: 10.6%)
$27.01
(+15%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (18x PE), but valuation improves significantly next year (11x PE) as earnings recover.
Trailing PE: 17.90 | Current EPS (TTM): $1.32
Bull Case
$41.00
(+75%)
Analyst growth 57.7%, PE expands to 19.7
Base Case
$37.27
(+59%)
Market implied 57.7%, PE stable at 17.9
Bear Case
$16.07
(-32%)
Severe decline -20.0%, PE contracts to 15.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 11.3 to 13.6
Stabilization Target:
$28.32
(+20.6%)
PE Expansion Potential:
+20.6%
Share & Embed Analysis
Last updated: September 13, 2026 3:44 AM ET
Data refreshes hourly during market hours. Next update: 4:44 AM
Data refreshes hourly during market hours. Next update: 4:44 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OPCH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$285 | 61 BUY |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$451 | 50 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$148 | 55 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$24 | 52 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$135 | 56 HOLD |
